Toxicity was mainly hematologic, with leukocytopenia being the most frequent cause of treatment delay.

We found that TM208 significantly inhibited tumor growth but did not cause loss of body weight or leukocytopenia.

Major toxicity was leukocytopenia and 64% and 80% of patients encountered leukocytopenia of Grade 3 or 4.